Berger Dietmar
Insider CIK 1739515 · ATRA Global Head of R&D · GILD Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GILD GILEAD SCIENCES, INC. | M Exercise deriv | 2026-09-10 | 2026-09-11 | 533 | — | $0 | 46,395 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | M Exercise | 2026-09-10 | 2026-09-11 | 533 | — | $0 | 19,785 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | F Tax w/h | 2026-09-10 | 2026-09-11 | 263 | $144.81 | $38.1K | 19,522 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | M Exercise deriv | 2026-09-10 | 2026-09-11 | 533 | — | — | 46,395 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | F Tax w/h | 2026-09-10 | 2026-09-11 | 263 | $144.81 | $38.1K | 19,522 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | M Exercise | 2026-09-10 | 2026-09-11 | 533 | — | — | 19,785 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | M Exercise deriv | 2026-06-10 | 2026-06-11 | 533 | — | $0 | 46,928 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | M Exercise | 2026-06-10 | 2026-06-11 | 533 | — | $0 | 19,515 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | F Tax w/h | 2026-06-10 | 2026-06-11 | 263 | $121.48 | $31.9K | 19,252 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | A Award deriv | 2026-03-10 | 2026-03-12 | 8,415 | — | $0 | 47,461 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | A Award deriv | 2026-03-10 | 2026-03-12 | 31,475 | — | $0 | 31,475 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | M Exercise deriv | 2026-03-10 | 2026-03-12 | 2,133 | — | $0 | 39,046 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | F Tax w/h | 2026-03-10 | 2026-03-12 | 1,063 | $148.56 | $157.9K | 18,982 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | M Exercise | 2026-03-10 | 2026-03-12 | 2,133 | — | $0 | 20,045 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | A Award | 2026-02-27 | 2026-03-02 | 8,530 | — | $0 | 17,912 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | M Exercise deriv | 2026-01-02 | 2026-01-05 | 16,326 | — | $0 | 41,179 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | F Tax w/h | 2026-01-02 | 2026-01-05 | 6,944 | $121.60 | $844.4K | 9,382 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | M Exercise | 2026-01-02 | 2026-01-05 | 16,326 | — | $0 | 16,326 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | A Award deriv | 2025-03-10 | 2025-03-12 | 37,710 | — | $0 | 37,710 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | A Award deriv | 2025-03-10 | 2025-03-12 | 8,530 | — | $0 | 57,505 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | A Award deriv | 2025-01-02 | 2025-01-03 | 48,975 | — | $0 | 48,975 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | F Tax w/h | 2019-05-07 | 2019-05-08 | 4,322 | $33.46 | $144.6K | 85,678 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2019-03-26 | 2019-03-27 | 15,000 | — | $0 | 90,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2019-02-06 | 2019-02-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2019-02-06 | 2019-02-08 | 25,000 | — | $0 | 75,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2018-05-07 | 2018-05-07 | 85,000 | — | $0 | 85,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2018-05-07 | 2018-05-07 | 50,000 | — | $0 | 50,000 | SEC↗ |